Safety Study of Darinaparsin in Combination With Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone (CHOP) to Treat Lymphoma

This study has been withdrawn prior to enrollment.
(Study enrollment was withdrawn as it is no longer the sponsor's intention to study this indication under this protocol.)
Sponsor:
Information provided by (Responsible Party):
Ziopharm
ClinicalTrials.gov Identifier:
NCT01139359
First received: June 4, 2010
Last updated: July 18, 2012
Last verified: July 2012
No Study Results Posted on ClinicalTrials.gov for this Study
Study was withdrawn before participants were enrolled.
  Study Status: This study has been withdrawn prior to enrollment.
  Estimated Study Completion Date: June 2011
  Estimated Primary Completion Date: June 2011 (Final data collection date for primary outcome measure)